Results 61 to 70 of about 1,098,228 (160)

PERIPAPILLARY ATROPHY WITH LARGE DEHISCENCES IN BRUCH MEMBRANE IN PSEUDOXANTHOMA ELASTICUM

open access: yes, 2015
PURPOSE: To describe a new set of findings in eyes with pseudoxanthoma elasticum, specifically large defects in Bruch membrane. METHODS: Retrospective review of the optical coherence tomography image obtained with the Heidelberg Spectralis of the ...
Spaide, R. F., Jonas, J. B.
core   +1 more source

Un nuevo gorgojo del "Prosopanche" (Oxycorynus parvulus Bruch) [PDF]

open access: yes, 2023
Esta especie difiere de O. hydnorae Pasc. y de O. helleri Bruch por su pequeña estatura, su cuerpo más convexo, de superficie más lustrosa, distintamente punteada y por la configuración de las antenas y tibias.Facultad de Ciencias Naturales y ...
Bruch, Carlos
core  

Determining Genetic Cause of Posterior Staphylomas in Eyes with Pathologic Myopia by Whole Exome Sequencing

open access: yesOphthalmology Science
Purpose: To identify genetic variants in posterior staphylomas in eyes with pathologic myopia using whole exome sequencing and to determine possible molecular mechanisms contributing to the pathogenesis.
Ziye Wang, MD   +11 more
doaj   +1 more source

Advancing Treatment of Degenerative Eye Diseases at the Nanoscale

open access: yesSmart Medicine, Volume 5, Issue 4, August 2026.
Nanotherapeutics possess the potential to overcome longstanding bottlenecks in treating degenerative ophthalmic diseases. With a highly tunable surface chemistry, nanotechnology platforms can be customized to navigate specific anatomical barriers in the eye and target pathways of diseases.
Li Yao Jin   +5 more
wiley   +1 more source

ApoE‐ and Cfh‐deficient mice exhibit structural and molecular features of human early–intermediate retinal degeneration

open access: yesAnimal Models and Experimental Medicine, Volume 9, Issue 7, Page 1420-1435, July 2026.
Age‐related macular degeneration (AMD) involves lipid dysregulation and complement overactivation. Here, we characterize a double‐knockout ApoE−/−/Cfh−/− mouse as a model of early–intermediate retinal degeneration. These mice exhibit retinal pigment epithelium thinning, Bruch's membrane thickening, lipid accumulation, enhanced C5b‐9 deposition ...
Sergio Recalde   +9 more
wiley   +1 more source

MS 007 Guide to Hilde Bruch, MD Papers (1928-1984) [PDF]

open access: yes, 2022
The Hilde Bruch, MD papers contains reprints, books, office files, patient records. The early gift of books and reprints, and the posthumous donation of books and papers have been integrated into the larger group of office records, making the total size ...
Bruch, Hilde, (1928-1984)
core   +1 more source

The new Bruch’s membrane opening – minimum rim width classification improves optical coherence tomography specificity in tilted discs

open access: yesClinical Ophthalmology, 2016
Gema Rebolleda, Alfonso Casado, Noelia Oblanca, Francisco J Muñoz-Negrete Department of Ophthalmology, Hospital Universitario Ramón y Cajal, Madrid, Spain Background and objective: To investigate and compare the false-positive (FP ...
Rebolleda G   +3 more
doaj  

Giant retinal pigment epithelium tears with membranous nephropathy: a case report and literature review

open access: yesBMC Ophthalmology
Background Kidney and eye diseases may be closely linked. Tears of the retinal pigment epithelium (RPE) have been reported to be related to kidney diseases, such as IgA nephropathy and light-chain deposition disease.
Rui Dou   +4 more
doaj   +1 more source

Les altérations papillaires du myope fort

open access: yesThe Pan African Medical Journal, 2014
En plus du vice de réfraction important occasionné, la myopie forte ou myopie axile maladie s 'accompagne de modifications dégénératives des tissus oculaires notamment la sclère et la rétine responsables de la malvoyance et des différentes complications ...
Hakima Elouarradi, Rajae Daoudi
doaj   +1 more source

Complement Factor H‐Based Therapeutics: A Comprehensive Overview

open access: yesEuropean Journal of Immunology, Volume 56, Issue 7, July 2026.
Complement factor H is a central regulator of the complement system and thus a target for therapeutic intervention. In this review, we provide an overview of past and current factor H‐based therapeutic concepts and modalities to treat complement‐mediated diseases.
Sebastiaan M. W. R. Hamers   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy